Research
An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study
BMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b2584 (Published 07 July 2009) Cite this as: BMJ 2009;339:b2584
Data supplement
Web Extra
Extra material supplied by the author
Files in this Data Supplement:
- Data Supplement - Recorded incidence of cardiovascular disease in the THIN cohort
Related articles
- Editorial Published: 07 July 2009; BMJ 339 doi:10.1136/bmj.b2673
- Paper Published: 09 December 1995; BMJ 311 doi:10.1136/bmj.311.7019.1539
- News Published: 11 August 2009; BMJ 339 doi:10.1136/bmj.b3273
- General Practice Published: 20 September 1997; BMJ 315 doi:10.1136/bmj.315.7110.722
- Research Methods & Reporting Published: 23 February 2009; BMJ 338 doi:10.1136/bmj.b375
- Research Published: 13 May 2010; BMJ 340 doi:10.1136/bmj.c2442
- Research Methods & Reporting Published: 28 May 2009; BMJ 338 doi:10.1136/bmj.b605
- Practice Published: 29 May 2008; BMJ 336 doi:10.1136/bmj.39554.624086.AD
- Primary Care Published: 27 November 2003; BMJ 327 doi:10.1136/bmj.327.7426.1267
- Research Published: 09 December 2010; BMJ 341 doi:10.1136/bmj.c6624
- Research Published: 16 August 2011; BMJ 343 doi:10.1136/bmj.d4656
- Research Published: 04 January 2012; BMJ 344 doi:10.1136/bmj.d8009
- Research Published: 24 May 2012; BMJ 344 doi:10.1136/bmj.e3318
- Research Published: 21 June 2012; BMJ 344 doi:10.1136/bmj.e4181
- Research Published: 02 May 2013; BMJ 346 doi:10.1136/bmj.f2573
- Letter Published: 11 June 2013; BMJ 346 doi:10.1136/bmj.f3737
- Research Published: 23 May 2017; BMJ 357 doi:10.1136/bmj.j2099
- RESEARCH Published: 05 July 2007; BMJ doi:10.1136/bmj.39261.471806.55
- Research Published: 19 July 2007; BMJ 335 doi:10.1136/bmj.39261.471806.55
- Research Published: 20 October 2020; BMJ 371 doi:10.1136/bmj.m3731
- Research Published: 17 September 2021; BMJ 374 doi:10.1136/bmj.n2244
- Research Published: 21 June 2023; BMJ 381 doi:10.1136/bmj-2022-072976
See more
- Why are UK cardiovascular deaths in under 65s rising again?BMJ May 19, 2025, 389 r1015; DOI: https://doi.org/10.1136/bmj.r1015
- Prescribing parkrun: medicalising a walk in the parkBMJ April 08, 2025, 389 r670; DOI: https://doi.org/10.1136/bmj.r670
- GPs can prescribe tirzepatide to priority patient groups from JuneBMJ April 02, 2025, 389 r665; DOI: https://doi.org/10.1136/bmj.r665
- Exercise referral rates for patients with risk of cardiovascular disease vary widely across England, study reportsBMJ February 12, 2025, 388 r287; DOI: https://doi.org/10.1136/bmj.r287
- Cardiovascular disease: Just one in 12 eligible people had health check last year, watchdog findsBMJ November 13, 2024, 387 q2518; DOI: https://doi.org/10.1136/bmj.q2518
Cited by...
- Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study
- QCovid 4 - Predicting risk of death or hospitalisation from COVID-19 in adults testing positive for SARS-CoV-2 infection during the Omicron wave in England
- Reviewing the use and quality of machine learning in developing clinical prediction models for cardiovascular disease
- Cross-sectional analysis of educational inequalities in primary prevention statin use in UK Biobank
- Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study
- Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm
- Educational inequalities in statin treatment for preventing cardiovascular disease: cross-sectional analysis of UK Biobank
- GPs familiarity with and use of cardiovascular clinical prediction rules: a UK survey study
- Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study
- Cardiovascular prevention: Frontiers in lipid guidelines
- Patient and Radiographic Factors Help to Predict Metal-on-Metal Hip Resurfacings with Evidence of a Pseudotumor
- Evaluating quality and its determinants in lipid control for secondary prevention of heart disease and stroke in primary care: a study in an inner London Borough
- Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study
- The performance of seven QPrediction risk scores in an independent external sample of patients from general practice: a validation study
- Can analyses of electronic patient records be independently and externally validated? The effect of statins on the mortality of patients with ischaemic heart disease: a cohort study with nested case-control analysis
- Unlinked data sources underestimate risk of cardiovascular disease
- Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study
- Authors' reply to Bird
- Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2
- Comparisons of established risk prediction models for cardiovascular disease: systematic review
- Identifying patients with suspected colorectal cancer in primary care: derivation and validation of an algorithm
- Identifying patients with suspected pancreatic cancer in primary care: derivation and validation of an algorithm
- Identifying patients with suspected gastro-oesophageal cancer in primary care: derivation and validation of an algorithm
- Original and REGICOR Framingham Functions in a Nondiabetic Population of a Spanish Health Care Center: A Validation Study
- Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study
- Performance of the ASSIGN cardiovascular disease risk score on a UK cohort of patients from general practice
- Advantages of QRISK2 (2010): the key issue is ethnicity and extent of reallocation
- Identifying women with suspected ovarian cancer in primary care: derivation and validation of algorithm
- Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database
- A simple risk score using routine data for predicting cardiovascular disease in primary care
- Individualising the risks of statins in men and women in England and Wales: population-based cohort study
- An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study
- Bespoke cohort studies needed
- Authors' reply
- QRISK may be less useful
- ASSIGN, QRISK, and validation
- QRISK or Framingham for predicting cardiovascular risk?